NY-ESO-1 (Protein | Antibody | cDNA Clone | ELISA Kit)

All NY-ESO-1 reagents are produced in house and quality controlled, including 15 NY-ESO-1 Gene, 1 NY-ESO-1 qPCR. All NY-ESO-1 reagents are ready to use.

NY-ESO-1 cDNA Clone (15)

NY-ESO-1 qPCR Primer (1)

NY-ESO-1 Related Research Area

NY-ESO-1 Background

NY-ESO-1 is another well-characterized CT antigen that appears to be the most immunogenic CT antigen known to date. Integrated humoral and cellular immune response against NY-ESO-1 are frequently observed in patients with tumors with NY-ESO-1 expression. As a member of CT antigens, NY-ESO-1 is expressed in a variety of malignant neoplasms, including melanomas, and esophageal, breast, prostate, urinary tract, ovarian, and lung cancers. Recently, immunohistochemical and molecular analytical approaches for the detection of NY-ESO-1 expression were compared, defining the reliability of each method. However, its clinical significance, e.g. in prognosis, in lung cancer is unclear.

Immune CheckpointImmunotherapyCancer ImmunotherapyTargeted Therapy

NY-ESO-1 References

  • Yoshida N, Abe H, Ohkuri T, et al. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance[J]. International journal of oncology, 2006, 28(5): 1089-1098.